CA2258736A1 - Prophylactic and therapeutic treatment of skin sensitization and irritation - Google Patents

Prophylactic and therapeutic treatment of skin sensitization and irritation Download PDF

Info

Publication number
CA2258736A1
CA2258736A1 CA002258736A CA2258736A CA2258736A1 CA 2258736 A1 CA2258736 A1 CA 2258736A1 CA 002258736 A CA002258736 A CA 002258736A CA 2258736 A CA2258736 A CA 2258736A CA 2258736 A1 CA2258736 A1 CA 2258736A1
Authority
CA
Canada
Prior art keywords
skin
agent
adverse
phenoxyacetic acid
reaction preventing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002258736A
Other languages
English (en)
French (fr)
Inventor
John J. Wille
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2258736A1 publication Critical patent/CA2258736A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
CA002258736A 1996-06-21 1997-06-17 Prophylactic and therapeutic treatment of skin sensitization and irritation Abandoned CA2258736A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/670,201 1996-06-21
US08/670,201 US5716987A (en) 1996-06-21 1996-06-21 Prophylactic and therapeutic treatment of skin sensitization and irritation

Publications (1)

Publication Number Publication Date
CA2258736A1 true CA2258736A1 (en) 1997-12-24

Family

ID=24689424

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002258736A Abandoned CA2258736A1 (en) 1996-06-21 1997-06-17 Prophylactic and therapeutic treatment of skin sensitization and irritation

Country Status (7)

Country Link
US (2) US5716987A (https=)
EP (1) EP0954300A4 (https=)
JP (1) JP2000512996A (https=)
AU (1) AU716125B2 (https=)
CA (1) CA2258736A1 (https=)
NZ (1) NZ333324A (https=)
WO (1) WO1997048369A2 (https=)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6605642B2 (en) 1999-04-05 2003-08-12 City Of Hope Inhibitors of formation of advanced glycation endproducts (AGES)
US7030133B2 (en) * 1999-04-05 2006-04-18 City Of Hope Inhibitors of formation of advanced glycation endproducts (AGEs)
CA2368688C (en) 1999-04-05 2009-08-11 City Of Hope Novel inhibitors of formation of advanced glycation endproducts (age's)
US7576131B2 (en) * 1999-06-04 2009-08-18 Metabolex, Inc. Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia
US6262118B1 (en) * 1999-06-04 2001-07-17 Metabolex, Inc. Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes and hyperlipidemia
AU1773601A (en) * 1999-11-18 2001-05-30 John D. Bolla Treatment or prevention of photoaging and skin cancer
US7199259B2 (en) * 2003-06-20 2007-04-03 Metabolex, Inc. Resolution of α-(phenoxy)phenylacetic acid derivatives
EP1682114A2 (en) * 2003-10-27 2006-07-26 City of Hope Methods of lowering lipid levels in a mammal
WO2005115384A2 (en) * 2004-05-25 2005-12-08 Metabolex, Inc. Bicyclic, substituted triazoles as modulators of ppar and methods of their preparation
CN1997633A (zh) * 2004-05-25 2007-07-11 麦它波莱克斯股份有限公司 作为ppar调节剂的取代的三唑及其制备方法
US7399493B2 (en) * 2004-07-16 2008-07-15 Wille John J Anti-irritant botanicals
US8252321B2 (en) 2004-09-13 2012-08-28 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
AU2005284908B2 (en) 2004-09-13 2011-12-08 Morningside Venture Investments Limited Biosynchronous transdermal drug delivery
US20070042026A1 (en) * 2005-03-17 2007-02-22 Wille John J Prophylactic and therapeutic treatment of topical and transdermal drug-induced skin reactions
WO2006127905A2 (en) 2005-05-24 2006-11-30 Chrono Therapeutics, Inc. Portable drug delivery device
US7714131B2 (en) * 2005-09-23 2010-05-11 Metabolex, Inc. Process for the stereoselective preparation of (−)-halofenate and derivatives thereof
WO2013006643A1 (en) 2011-07-06 2013-01-10 The Parkinson's Institute Compositions and methods for treatment of symptoms in parkinson's disease patients
US10105487B2 (en) 2013-01-24 2018-10-23 Chrono Therapeutics Inc. Optimized bio-synchronous bioactive agent delivery system
AU2016211330A1 (en) 2015-01-28 2017-08-03 Chrono Therapeutics Inc. Drug delivery methods and systems
US10679516B2 (en) 2015-03-12 2020-06-09 Morningside Venture Investments Limited Craving input and support system
CA3049529A1 (en) 2017-01-06 2018-07-12 Chrono Therapeutics Inc. Transdermal drug delivery devices and methods
US11596779B2 (en) 2018-05-29 2023-03-07 Morningside Venture Investments Limited Drug delivery methods and systems
US12397141B2 (en) 2018-11-16 2025-08-26 Morningside Venture Investments Limited Thermally regulated transdermal drug delivery system
US11865602B2 (en) * 2020-01-16 2024-01-09 Ehc Inc. Paintless dent removal tool, system and method

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2383662A1 (fr) * 1977-03-15 1978-10-13 Cassenne Lab Sa Nouvelles compositions a usage cosmetique
JPS55133304A (en) * 1979-04-05 1980-10-17 Shiseido Co Ltd Perfume controller
US4524214A (en) * 1983-11-03 1985-06-18 Stauffer Chemical Company Process for forming esters of glyoxylic acids
US5120545A (en) * 1990-08-03 1992-06-09 Alza Corporation Reduction or prevention of sensitization to drugs
DE4225794C2 (de) * 1992-07-31 1994-12-08 Schuelke & Mayr Gmbh Tb-wirksame Carbonsäuren

Also Published As

Publication number Publication date
EP0954300A2 (en) 1999-11-10
WO1997048369A3 (en) 1998-02-05
WO1997048369A2 (en) 1997-12-24
JP2000512996A (ja) 2000-10-03
AU716125B2 (en) 2000-02-17
US6670395B1 (en) 2003-12-30
US5716987A (en) 1998-02-10
EP0954300A4 (en) 2004-10-20
NZ333324A (en) 2000-08-25
AU3372797A (en) 1998-01-07

Similar Documents

Publication Publication Date Title
US5716987A (en) Prophylactic and therapeutic treatment of skin sensitization and irritation
US5686100A (en) Prophylactic and therapeutic treatment of skin sensitization and irritation
MXPA97003694A (en) Profilactico and therapeutic treatment of the sensitization and irritation of the p
AU695804B2 (en) Prophylactic treatment of allergic contact dermatitis
US5843979A (en) Transdermal treatment with mast cell degranulating agents for drug-induced hypersensitivity
US5665378A (en) Transdermal therapeutic formulation
EP0612525B1 (en) Transdermal treatment with mast cell degranulating agents for drug-induced hypersensitivity
JP4230109B2 (ja) 両性界面活性剤、アルコキシル化セチルアルコールおよび極性薬剤を含む医薬組成物
MXPA97003693A (en) Profilactic treatment of allergic dermatitis by conta
JP2002536321A (ja) 製薬組成物
EP1644004A2 (en) Tropical therapy for the treatment of migraines, muscle sprains, muscle spasm, spasticity and related conditions
Goette et al. Allergic contact dermatitis to topical fluorouracil
WO1996023522A1 (en) Treatment of diabetic neuropathy
WO1997018782A1 (en) Treatment with calcium channel blockers for drug-induced hypersensitivity
US20030054030A1 (en) Method and compositions for the treatment of pruritus
JP2725776B2 (ja) コルチコステロイドと感作性薬物との同時投与による接触アレルギーの予防
JPH09110680A (ja) 皮膚炎治療貼付剤
JPH01299217A (ja) 硬膏剤
CN112891242A (zh) 一种用于祛斑美白抗炎的组合物及其应用
JPH03227921A (ja) ケロイド治療剤
JPH1180031A (ja) 外用剤及び経皮又は経粘膜吸収性を増進する方法

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued
FZDE Discontinued

Effective date: 20080131